H. Rübben

7.8k total citations · 1 hit paper
319 papers, 5.6k citations indexed

About

H. Rübben is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Urology. According to data from OpenAlex, H. Rübben has authored 319 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 161 papers in Surgery, 75 papers in Pulmonary and Respiratory Medicine and 67 papers in Urology. Recurrent topics in H. Rübben's work include Bladder and Urothelial Cancer Treatments (100 papers), Urinary and Genital Oncology Studies (49 papers) and Urological Disorders and Treatments (46 papers). H. Rübben is often cited by papers focused on Bladder and Urothelial Cancer Treatments (100 papers), Urinary and Genital Oncology Studies (49 papers) and Urological Disorders and Treatments (46 papers). H. Rübben collaborates with scholars based in Germany, Hungary and Austria. H. Rübben's co-authors include S. Krege, T. Otto, Wolfgang Lutzeyer, G. Lümmen, F. vom Dorp, H.H. Dahm, H. Sperling, Tibor Szarvas, Kurt Werner Schmid and Μ. Goepel and has published in prestigious journals such as Nature Medicine, PLoS ONE and Cancer.

In The Last Decade

H. Rübben

293 papers receiving 5.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prognostic Parameters in Superficial Bladder Cancer: An Analysis of 315 Cases

1982 325 citations H. Rübben et al. profile →

Peers

Countries citing papers authored by H. Rübben

Since Specialization

Citations

This map shows the geographic impact of H. Rübben's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Rübben with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Rübben more than expected).

Fields of papers citing papers by H. Rübben

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Rübben. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Rübben. The network helps show where H. Rübben may publish in the future.

Co-authorship network of co-authors of H. Rübben

This figure shows the co-authorship network connecting the top 25 collaborators of H. Rübben. A scholar is included among the top collaborators of H. Rübben based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Rübben. H. Rübben is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Integrated <sup>68</sup>Gallium Labelled Prostate-Specific Membrane Antigen-11 Positron Emission Tomography/Magnetic Resonance Imaging Enhances Discriminatory Power of Multi-Parametric Prostate Magnetic Resonance Imaging 2018 ·Urologia Internationalis ·(unknown), Johannes Grueneisen, Susanne Lütje, Lino M. Sawicki, Saravanabavaan Suntharalingam, Stephan Tschirdewahn, Michael Forsting, H. Rübben, Ken Herrmann, Lale Umutlu, Axel Wetter	31
2	Testosteronmangel – ein unterschätztes Risiko für Männer? 2013 ·Der Urologe ·(unknown), Jan Kramer, (unknown), H. Rübben, (unknown), Tibor Szarvas	2
3	Skeletal muscle-derived cell implantation in female patients with stress urinary incontinence: A multicenter, randomized, parallel-group, placebo-controlled clinical study 2012 ·(unknown), (unknown), (unknown), H. Rübben	1
4	Pudendal nerve block in HDR-brachytherapy patients: do we really need general or regional anesthesia? 2012 ·World Journal of Urology ·M. Schenck, (unknown), H. Rübben, Martin Stuschke, Tim Schneider, A. Eisenhardt, R Rossi	8
5	Ergebnisse einer neuen Technik der Meatusplastik im Rahmen der geschlechtsangleichenden Operation von Mann zu Frau 2011 ·Journal für Kardiologie (Krause & Pachernegg GmbH) ·(unknown), (unknown), (unknown), H. Rübben, (unknown)	1
6	Hodenhochstand: Aspekte der Behandlung 2010 ·Urologe A ·(unknown), H. Rübben	1
7	Operative Therapie des Nierenzellkarzinoms 2010 ·Aktuelle Urologie ·Frederik C. Roos, H. Rübben, Christian G. Stief, Michael Stöckle, (unknown)	4
8	Angiogenic Switch of Angiopietins-Tie2 System and Its Prognostic Value in Bladder Cancer 2008 ·Clinical Cancer Research ·Tibor Szarvas, Tobias Jäger, Martin Tötsch, F. vom Dorp, Carsten Kempkensteffen, Ilona Kovalszky, Imre Romics, Süleyman Ergün, H. Rübben	32
9	Stellenwert der Lymphadenektomie beim Prostatakarzinom 2008 ·Der Urologe ·Thorsten Schlomm, (unknown), Hans Heinzer, H. Rübben, Hartwig Huland, Markus Graefen	2
10	Der Stellenwert der Targeted-Therapie beim Prostatakarzinom 2008 ·Der Urologe ·(unknown), F. vom Dorp, M. Schenck, Markus Becker, Jochen Heß, H. Rübben	0
11	Insertion/deletion polymorphism in the promoter of NFKB1 as a potential molecular marker for the risk of recurrence in superficial bladder cancer 2007 ·International Journal of Clinical Pharmacology and Therapeutics ·(unknown), Laren Becker, (unknown), H. Rübben, A. Eisenhardt, Winfried Siffert	50
12	ACE gene I/D and NOS3 G894T polymorphisms and response to sildenafil in men with erectile dysfunction 2003 ·Urology ·A. Eisenhardt, H. Sperling, Ekkehard W. Hauck, Hartmut Porst, Christian G. Stief, H. Rübben, Norbert Müller, Winfried Siffert	50
13	Cryptorchidism: Fowler-Stephens procedure or autotransplantation—a new experimental model 2000 ·Urology ·H. Sperling, G. Lümmen, (unknown), H. Rübben	5
14	DIE DETRUSORMYEKTOMIE (AUTOAUGMENTATION) IN DER BEHANDLUNG DER HYPERREFLEXIVEN LOW-COMPLIANCE-BLASE 1999 ·M. Stöhrer, Μ. Goepel, G. Krämer, D. Löchner‐Ernst, H. Rübben	3
15	Efficacy and tolerability of 2 application forms (s. c. and i. m.) of decapeptyl® depot in patients with advanced prostate cancer 1999 ·Der Urologe ·K. F. Klippel, (unknown), D. Jocham, H. Rübben, Barry Kurt Moser, Amitabh Gulati	4
16	Erectile dysfunction. Is an oral medication during the diagnostic pathway indicated? 1999 ·Der Urologe ·H. Sperling, G. Lümmen, (unknown), H. Rübben	2
17	[Diagnosis of bladder calculi]. 1997 ·PubMed ·E Brändle, Richard E. Hautmann, P. Alken, Albrecht Hesse, (unknown), (unknown), (unknown), (unknown), H. Rübben, H. Melchior	3
18	Second-line chemotherapy with mitomycin-C and 5-fluorouracil in the treatment of refractory metastatic cancer of the urinary bladder 1997 ·Der Urologe ·T. Otto, S. Krege, Brandon Otto, Μ. Goepel, H. Rübben	3
19	A modified prostatic urolume wallstent for healthy patients with symptomatic benign prostatic hyperplasia: A european multicenter study 1994 ·Urology ·Giorgio Guazzoni, Francesco Montorsi, Christian Coulange, (unknown), Vito Pansadoro, H. Rübben, Jean‐Pierre Sarramon, G. Williams	34
20	Multicellular Bladder Tumor Spheroids in Coculture with Human Endothelial Cell Monolayers 1987 ·Urologia Internationalis ·Ruth Knüchel, Ferdinand Hofstädter, J. Feichtinger, (unknown), (unknown), (unknown), H. Rübben, (unknown), (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact